Azintuxizumab (Anti-SLAMF7 / CS1)

Azintuxizumab (Anti-SLAMF7 / CS1) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.
Supplier Selleck Chemicals
Product # A3061
Sku # A3061-1mg*25
Pricing 1mg*25, $5070.00
Feedback